Regulation of hexokinase and glucose-6-phosphate dehydrogenase genes expression at norm and pathology (original) (raw)
Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells
Mary Board
Biochemical Journal, 1990
View PDFchevron_right
Expression of hexokinase and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase genes in ERN1 knockdown glioma U87 cells: effect of hypoxia and glutamine or glucose deprivation
Rostyslav Marunych
View PDFchevron_right
GLUCOSE METABOLISM IN CANCER CELLS
Naushin shaikh
2020
View PDFchevron_right
Hypoxia-inducible Factor-1-mediated Expression of the 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) Gene. ITS POSSIBLE ROLE IN THE WARBURG EFFECT
Jaime Caro
Journal of Biological Chemistry, 2001
View PDFchevron_right
Inhibition of the pentose phosphate pathway by dichloroacetate unravels a missing link between aerobic glycolysis and cancer cell proliferation
Bénédicte Jordan
Oncotarget, 2015
View PDFchevron_right
Expression and hypoxia-responsiveness of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 in mammary gland malignant cell lines
Jaime Caro
Acta Biochimica Polonica, 2005
View PDFchevron_right
Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatases in cancer
Abdullah Yalcin
Experimental and molecular …, 2009
View PDFchevron_right
Hypoxia-inducible Factor-1-mediated Expression of the 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) Gene
Nianli Sang
Journal of Biological Chemistry, 2001
View PDFchevron_right
Disrupting glucose-6-phosphate isomerase fully suppresses the “Warburg effect” and activates OXPHOS with minimal impact on tumor growth except in hypoxia
Masa Zdralevic
Oncotarget, 2017
View PDFchevron_right
Regulation of Energy Homeostasis in Cancer
Şermin Tetik
Advances in pharmacology and clinical trials, 2022
View PDFchevron_right
Fructose 2,6-Bisphosphate in Cancer Cell Metabolism
Anna Manzano
Frontiers in Oncology
View PDFchevron_right
Frequent alteration of the protein synthesis of enzymes for glucose metabolism in hepatocellular carcinomas
Mitsugi Shimoda, Takayuki Shimizu
Journal of Gastroenterology, 2013
View PDFchevron_right
Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo
Jaime Caro
FEBS Letters, 2003
View PDFchevron_right
Inhibition of Glycolysis Suppresses Cell Proliferation and Tumor Progression In Vivo: Perspectives for Chronotherapy
Michal Zeman
International Journal of Molecular Sciences, 2021
View PDFchevron_right
Metabolic Control of Glycolysis in Normal and Tumor Permeabilized Cells1
Mario Gosalvez Gosalvez
1978
View PDFchevron_right
Deregulation of glycolysis in cancer: glyceraldehyde-3-phosphate dehydrogenase as a therapeutic target
Anna Kudryavtseva
Expert Opinion on Therapeutic Targets, 2013
View PDFchevron_right
Cell Death & Disease A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo
Tarik Regad, David J Boocock
Cell Death & Disease, 2018
View PDFchevron_right
Two high-rate pentose-phosphate pathways in cancer cells
Alberto Miceli
Scientific Reports, 2020
View PDFchevron_right
Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma
amedeo columbano
Frontiers in oncology, 2017
View PDFchevron_right
The pentose phosphate pathway: An antioxidant defense and a crossroad in tumor cell fate
Manuela Polimeni, Elisabetta Aldieri
Free Radical Biology and Medicine, 2012
View PDFchevron_right
The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition
chih-wei Chen
Oncotarget, 2018
View PDFchevron_right
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo
Paola Stiuso
Cell death & disease, 2018
View PDFchevron_right
Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer
Douglas Spitz, Melissa Fath
Redox Biology, 2015
View PDFchevron_right
The Pentose Phosphate Pathway Dynamics in Cancer and Its Dependency on Intracellular pH
Adil Bashir
Metabolites
View PDFchevron_right
Dynamic scenario of metabolic pathway adaptation in tumors and therapeutic approach
Francesca Bianchini
Oncoscience, 2015
View PDFchevron_right
Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism?
Laszlo Boros
Medical Hypotheses, 1998
View PDFchevron_right
Glucose Metabolism in Cancer and Ischemia: Possible Therapeutic Consequences of the Warburg Effect
Špela Šalamon
View PDFchevron_right
Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis
Ajay Verma
Journal of Biological Chemistry, 2002
View PDFchevron_right
Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma
Alvaro Marín-hernández, Rafael Moreno-Sánchez
The International Journal of Biochemistry & Cell Biology, 2010
View PDFchevron_right
Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression
Kang Kim
Journal of Hepatology, 2005
View PDFchevron_right